The Guidewire Policy & Analysis

The Guidewire

An editorial brief on the profession
The Accreditation Brief

The One Accreditor Question

Should podiatric residency training move under the ACGME? The honest answer isn’t a verdict — it’s a single disagreement that decides everything else.

By Peter Sorensen, DPM Two cases, one crux

Every few years the question resurfaces, and every time it gets argued as if it were about respect. It isn’t. Strip away the status anxiety and a sharper version emerges — one where both sides are serious, evidence-based, and almost entirely talking past each other. Below are the two strongest cases, built to their best form, followed by the single point on which they actually diverge.

Case I — For Single Accreditation
The load-bearing pillar The experiment has already been run. From 2015–2020, osteopathic medicine merged into ACGME single accreditation, carrying the identical fear of being absorbed. The solution was Osteopathic Recognition — a designation inside ACGME for programs preserving their distinctive training. DOs stopped being a separate tier. A “Podiatric Recognition” pathway isn’t speculative; it’s a copy of a thing that works.
The Case For

Join the building before litigating from the parking lot.

  1. It collapses the “separate, therefore lesser” frame. So long as podiatry sits in its own silo, every credentialing committee and skeptical orthopod has a structural reason to treat it as adjacent-to-medicine. Shared accreditation removes the cleanest argument the skeptics have.
  2. It attacks the worst internal problem — program variance. The real scandal isn’t legitimacy; it’s the spread between surgically rich programs and those that can’t generate volume. ACGME’s machinery — Milestones, CLER, enforced minimums, continuous data — is far better resourced to raise the floor.
  3. Interoperability. Off-service rotations in vascular, ID, endocrine, and plastics stop being negotiated favors and start counting inside one shared framework. Residents become mobile within a single system instead of two.
  4. Pipeline defense. A profession fighting declining applicant numbers benefits from the strongest possible “this is mainstream medicine” signal at the front door. ACGME accreditation is that signal.
  5. It’s the prerequisite for any larger ambition. Whatever the long game — broader recognition, federal parity, eventual convergence — none of it is arguable while podiatry maintains a separate accreditation bureaucracy.
Case II — Against Single Accreditation
The load-bearing pillar The osteopathic analogy breaks at the joint. DOs walked into ACGME as full physicians with an unlimited license in all 50 states — accreditation was the last formality. Podiatry’s separateness is written into 50 state practice acts that define a limited license by anatomy. ACGME has no authority over what a DPM can legally bill or cut. Joining doesn’t erase the difference — it spotlights the one resident in the building whose scope is set by statute, not by training.
The Case Against

The thing that makes podiatry separate is upstream of accreditation.

  1. “Raising the floor” is a shrinking argument in a quality costume. ACGME standards would close weak programs — but those slots evaporate, they don’t transfer. For a profession already cutting its own pipeline, losing training capacity to case-minimum and resource requirements isn’t corrective. It’s subtractive.
  2. You’d negotiate from a fractured house. Podiatry can’t unify its own boards internally. Walking in with that disunity means you don’t dictate terms — you accept whatever structure they offer a tiny minority with no votes. The realistic risk isn’t lost identity; it’s second-tier status made official.
  3. The scope logic runs backwards. Scope is statutory, won state by state. Accreditation has no legal bearing on it. You’d spend the profession’s political capital on a change that delivers no scope gain — and arguably signals subordination at the statehouse.
  4. It’s a structural sledgehammer for a perception problem. The legitimacy gap is real but is largely visibility plus specific credentialing fights — VA, military, privileging, payer panels. Those are winnable directly: cheaper, faster, without dissolving your own accreditor or surviving a transition you may not have the bandwidth to absorb.
The Crux

Notice what the two cases never actually argue about. The case for assumes podiatry’s core problem is one a stronger accreditor can fix. The case against assumes that problem lives entirely upstream — in statute, in board fragmentation, in a thin public footprint — where no accreditor can reach. Both are internally coherent. They simply locate the disease in different organs.

Which means the real debate is narrower, and more answerable, than the usual shouting match: not “is ACGME good,” but a single diagnostic question.

Everything else is downstream of this
Is podiatry’s central problem one that a stronger accreditor can fix — or one that is upstream of accreditation entirely?

The against-case quietly bets that podiatry can solve legitimacy and enrollment from inside its own walls. The last decade is not strong evidence for that bet. The for-case quietly bets that ACGME would accept podiatry on terms that preserve the degree and the scope — which is precisely the fight, not a given. Answer the crux honestly and the rest of the argument resolves on its own.

THE GUIDEWIRE — POLICY & ANALYSIS
A two-sided brief. The framing is the argument; the verdict is yours.
© 2026 Peter Sorensen, DPM